Israeli breakthrough offers hope: Simple blood test could detect lung cancer

Researchers are developing a simple blood test to detect lung cancer in its early stages, potentially improving survival rates. The test aims to overcome the limitations of expensive and sometimes inconclusive low-dose CT screenings.
Why it matters
Early detection is the most critical factor in successfully treating lung cancer, which is currently often diagnosed at advanced stages.
Lung cancer claims more lives worldwide than any other type of cancer. But the fight against it does not begin in the treatment room. It begins much earlier, at the moment the disease is detected. Lung cancer treatment has advanced dramatically in recent years, but the chances of success depend largely on when it is diagnosed: The earlier the disease is detected, the greater the likelihood of treating it successfully. Alongside the development of new treatments, an equally important race is underway to find ways of identifying cancer in its earliest stages, before it causes significant symptoms. Lung cancer is not a single disease but is divided into two main groups: non-small cell lung cancer, or NSCLC, the most common type, and small cell lung cancer, or SCLC, which is considered more aggressive.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in